
Study Period | 2019 - 2030 |
Market Size (2025) | USD 6.91 Billion |
Market Size (2030) | USD 10.88 Billion |
CAGR (2025 - 2030) | 9.50 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Respiratory And Anesthesia Disposables Market Analysis
The Respiratory And Anesthesia Disposables Market size is estimated at USD 6.91 billion in 2025, and is expected to reach USD 10.88 billion by 2030, at a CAGR of 9.5% during the forecast period (2025-2030).
Market growth is projected to be driven by rising respiratory disorders, an uptick in surgeries, and widespread tobacco smoking.
Globally, respiratory diseases like COPD, tuberculosis, asthma, and sleep apnea are on the rise due to factors including air pollution, exposure to occupational chemicals and dust, recurrent childhood respiratory infections, and other environmental influences. This is expected to increase the demand for respiratory disposables products, hence propelling the market growth over the projected period. For instance, data released by the American Lung Association in July 2024 revealed that 44.2 million Americans, or 13.5% of the population, have been diagnosed with asthma. Among different age groups, adults aged 18-55 showed the highest lifetime prevalence rate at 16.8%. In 2023, the asthma diagnosis rate for females was 14.2%, which is roughly 12% higher than the 12.7% rate for males.
Similarly, as per the Australian Institutes of Health and Welfare (AIHW) in July 2024, asthma represented 2.5% of the overall disease burden and constituted 35% of the total burden for all respiratory conditions in 2023. It emerged as the primary cause of the disease burden among children aged 1–9 years. Thus, the high burden of respiratory diseases is expected to contribute to market growth.
Additionally, the expected increase in number of surgeries that require anesthesia raises the demand for various anesthesia disposables products such as oxygen masks, suction catheters, tubes, and others. This, in turn, is expected to boost the market growth over the forecast period. For instance, aa per British Heart Foundation Report published in July 2024, in England, cardiac waiting lists expanded to 421,433 by the end of May 2024, reflecting an increase of 2,394 compared to the previous month. This growing backlog is expected to drive demand for respiratory and anesthesia disposables, as healthcare providers prioritize efficient patient management to address the rising numbers, thereby boosting the market growth.
Moreover, the rising new product launches are expected to increase the availability of products in the market, thereby contributing to market growth. For instance, in June 2024, Applied Medical Technology, Inc. unveiled IntelAir, a nasal airway support system. This single-use device secures the airway, prevents cannula migration, and ensures airway clarity. Owing to such launches the products are available to the end user expected to increase its demand is likely to propel the market growth.
Therefore, owing to the aforementioned factors, such as the high burden of respiratory disorders and increasing surgical procedures, the studied market is expected to grow over the forecast period. However, the high cost of consumables is likely to impede the growth of the respiratory and anesthesia disposables market over the forecast period.
Respiratory And Anesthesia Disposables Market Trends
Chronic Obstructive Pulmonary Disease Segment is Expected to Witness Significant Growth Over the Forecast Period
The chronic obstructive pulmonary diseases (COPD) segment is anticipated to witness significant growth in the segment over the forecast period owing to factors such as the increasing cases of chronic obstructive pulmonary diseases among the population, rising technological advancements in consumables, and new product launches.
Chronic respiratory diseases such as COPD require long-term management and frequent use of disposable respiratory equipment, such as masks, nebulizers, and ventilator circuits. Hence, the growing prevalence of COPD is expected to spur the demand for respiratory disposables, contributing to segment growth. For instance, an article published in the ERS Journal in August 2023 projected that by 2050, approximately 645.6 million individuals (454.4 million men and 191.2 million women) will be affected by COPD across globe. This figure indicates a 36% relative increase in global prevalence compared to the previous year. Thus, the expected increase in the number of patients suffering from COPD, a serious public health issue, is expected to increase the demand for effective respiratory disposables such as oxygen masks, nebulizers, and others, hence propelling the segment's growth.
The increasing awareness campaign for COPD is expected to drive the demand for respiratory and anesthesia disposables products and is anticipated to spur the studied segment growth. In November 2023, during COPD Awareness Month, the American Lung Association, with support from Sanofi and Regeneron, launched the "COPD for Life" campaign. Chronic obstructive pulmonary disease (COPD) is a long-term lung condition that impairs breathing. This initiative aims to enhance the quality of life for individuals who've battled the disease for a decade or longer, encouraging them to lead more active and fulfilling lives.
Furthermore, the the strategic activities by the industry players such as partnership and collaboration are anticipated to augment the segment's growth over the forecast period. For instance, in March 2023, BHV Partners unveiled a new venture, Conus Airway, focused on crafting medical devices that enhance anesthesia and surgical procedures related to the respiratory tract. These innovative devices facilitate simultaneous endotracheal dilation and ventilation, aiming to mitigate risks tied to respiratory tract surgeries. Such partnership are expected to bolster the market growth over the forecast period.
Thus, owing to the abovementioned factors, such as the high burden of chronic obstructive pulmonary diseases among the population and increasing technological advancements, the studied segment is expected to show considerable growth over the forecast period.

North America is Expected to Have the Significant Market Share Over the Forecast Period
North America is expected to hold a significant share in the respiratory and anesthesia disposables market over the forecast period owing to factors such as the high burden of respiratory diseases, an increasing number of surgical procedures owing to chronic diseases and road accidents, and the high prevalence of tobacco smoking.
The prevalence of respiratory diseases is on the rise due to factors like aging populations, urbanization, and environmental pollution. This growing burden necessitates a higher use of respiratory devices and medications, which generates a greater need for safe disposal solutions.
For instance, as per Canadian Institutes of Health Information data published in February 2024, in the 2022–2023 period, respiratory illnesses ranked among the top 10 reasons for hospitalizations, making up 32% of all hospitalizations for Canadians aged 0 to 4. Hospitalizations for seasonal influenza in this age group reached 2,444, mirroring figures from the 2019–2020 period. Additionally, there were significant surges in hospitalizations for other respiratory ailments: stays for lower respiratory infections, including acute bronchitis, jumped from 9,501 in 2020 to 19,909 in 2023. Similarly, pneumonia-related hospitalizations nearly tripled, escalating from 3,447 to 9,871 during the same timeframe. Thus, the high number of COPD cases among the population is leading to respiratory diseases, which in turn is expected to increase the demand for respiratory devices such as masks, breathing bags, and others. This is anticipated to augment the market growth over the projected period.
Furthermore, the growing number of new product launches and approvals increases the availability of disposable products in the market, thereby contributing to market growth in the region. For instance, in April 2024, ABM Respiratory Care announced the expanded indication granted to the BiWaze Clear System. The oscillating lung expansion (OLE) therapy of BiWaze Clear is intended to remove airway obstructions caused by retained secretions in the lower airways, as well as re-expand collapsed areas of the lungs, prevent respiratory tract infections, and enhance gas exchange and oxygenation.
Given the high burden of respiratory diseases and a surge in new product launches, the market under study is poised for growth during the forecast period.

Respiratory And Anesthesia Disposables Industry Overview
The respiratory and anesthesia disposables market is a fragmented market with the presence of several players across the globe. The companies are adopting various key strategies such as collaboration, product launches, and others to retain their position in the market. Some of the players in the market are Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Becton, Dickinson and Company (BD), Teleflex Incorporated, Armstrong Medical Industries, Inc., and Allied Healthcare Products, Inc., among others.
Respiratory And Anesthesia Disposables Market Leaders
-
Koninklijke Philips N.V.
-
Boston Scientific Corporation
-
Teleflex Incorporated
-
Medtronic PLC
-
Becton, Dickinson and Company
- *Disclaimer: Major Players sorted in no particular order

Respiratory And Anesthesia Disposables Market News
- April 2024: Fisher & Paykel Healthcare Corporation Limited has introduced the F&P Solo Nasal mask in the United States for managing obstructive sleep apnea (OSA). Featuring an AutoFit design, the F&P Solo streamlines the setup process by allowing users to easily position the mask on their face and make adjustments with a single touch.
- March 2024: Medline acquired the manufacturing rights and intellectual property of AG Cuffill from Hospitech Respiration Ltd. This compact, intuitive device, resembling a syringe, accurately measures both the pressure and volume of airway cuffs across all clinical settings.
Respiratory And Anesthesia Disposables Industry Segmentation
The respiratory and anesthesia disposables are medical consumables meant for single use in order to prevent cross-contamination among patients. These disposables greatly reduce the economic burden on the healthcare systems by eliminating the risk of re-infection, as they can be cast off after a single-use or material deterioration.
The respiratory and anesthesia disposables market is segmented by type, application, end-user, and geography. By type the market is segmented as laryngoscope, tubes, masks, breathing circuits, resuscitators, breathing bags, filters, and other types. By application the market is segmented as chronic obstructive pulmonary disease, surgical procedures, asthma, sleep apnea, and emergency use. By end-user the market is segmented as hospitals, clinics, and trauma centers. By geography the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
The report offers the value (in USD) for the above segments.
Type | Laryngoscope | ||
Tubes | |||
Masks | |||
Breathing Circuits | |||
Resuscitators | |||
Breathing Bags | |||
Filters | |||
Other Types | |||
Application | Chronic Obstructive Pulmonary Disease (COPD) | ||
Surgical Procedures | |||
Asthma | |||
Sleep Apnea | |||
Emergency Use | |||
End-User | Hospitals | ||
Clinics | |||
Trauma Centers | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Respiratory And Anesthesia Disposables Market Research FAQs
How big is the Respiratory And Anesthesia Disposables Market?
The Respiratory And Anesthesia Disposables Market size is expected to reach USD 6.91 billion in 2025 and grow at a CAGR of 9.5% to reach USD 10.88 billion by 2030.
What is the current Respiratory And Anesthesia Disposables Market size?
In 2025, the Respiratory And Anesthesia Disposables Market size is expected to reach USD 6.91 billion.
Who are the key players in Respiratory And Anesthesia Disposables Market?
Koninklijke Philips N.V., Boston Scientific Corporation, Teleflex Incorporated, Medtronic PLC and Becton, Dickinson and Company are the major companies operating in the Respiratory And Anesthesia Disposables Market.
Which is the fastest growing region in Respiratory And Anesthesia Disposables Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Respiratory And Anesthesia Disposables Market?
In 2025, the North America accounts for the largest market share in Respiratory And Anesthesia Disposables Market.
What years does this Respiratory And Anesthesia Disposables Market cover, and what was the market size in 2024?
In 2024, the Respiratory And Anesthesia Disposables Market size was estimated at USD 6.25 billion. The report covers the Respiratory And Anesthesia Disposables Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Respiratory And Anesthesia Disposables Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Respiratory And Anesthesia Disposables Industry Report
Statistics for the 2025 Respiratory And Anesthesia Disposables market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Respiratory And Anesthesia Disposables analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.